{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+samples+collected&page=67", "query": { "intervention": "Blood samples collected", "page": 67 }, "page_size": 10 }, "pagination": { "page": 67, "page_size": 10, "total_count": 4266, "total_pages": 427, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+samples+collected&page=68&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+samples+collected&page=66&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T12:31:06.135Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07323641", "title": "Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Non-Small Cell Carcinoma" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Osimertinib", "type": "DRUG" }, { "name": "Survey Administration", "type": "OTHER" }, { "name": "Telisotuzumab Vedotin", "type": "BIOLOGICAL" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER", "BIOLOGICAL" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2026-02-19", "completion_date": "2028-02-01", "has_results": false, "last_update_posted_date": "2026-04-20", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07323641" }, { "nct_id": "NCT03889522", "title": "The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Bioelectrical Impedance Analysis", "type": "DIAGNOSTIC_TEST" }, { "name": "Total Body Dual-energy X-ray Absorptiometry", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood draw", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "5 Years to 17 Years" }, "enrollment_count": 21, "start_date": "2019-05-01", "completion_date": "2021-02-25", "has_results": false, "last_update_posted_date": "2026-03-16", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03889522" }, { "nct_id": "NCT04852822", "title": "Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 350, "start_date": "2021-03-18", "completion_date": "2024-07-01", "has_results": false, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 11, "location_summary": "Duarte, California • Orange, California • Washington D.C., District of Columbia + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04852822" }, { "nct_id": "NCT07658677", "title": "Cannabis Gummy for the Improvement of Sleep and Quality of Life in Patients With Cancer, Pillow Trial", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hematopoietic and Lymphatic System Neoplasm", "Malignant Solid Neoplasm" ], "interventions": [ { "name": "Actigraphy", "type": "OTHER" }, { "name": "Best Practice", "type": "OTHER" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Ecological Momentary Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Single Agent Therapy", "type": "DRUG" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DRUG" ], "sponsor": "Theodore Brasky PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2027-01-15", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07658677" }, { "nct_id": "NCT00540722", "title": "Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Adult Giant Cell Glioblastoma", "Adult Glioblastoma", "Adult Gliosarcoma", "Recurrent Adult Brain Tumor" ], "interventions": [ { "name": "R-(-)-gossypol acetic acid", "type": "DRUG" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2008-01", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2017-08-11", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Tampa, Florida • Baltimore, Maryland + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00540722" }, { "nct_id": "NCT01573429", "title": "Bisphenol A Controlled Exposure Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "deuterated-Bisphenol A (d-BPA)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "National Institute of Environmental Health Sciences (NIEHS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "25 Years to 45 Years" }, "enrollment_count": 38, "start_date": "2012-07-18", "completion_date": "2020-06-16", "has_results": false, "last_update_posted_date": "2021-11-18", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 1, "location_summary": "Research Triangle Park, North Carolina", "locations": [ { "city": "Research Triangle Park", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01573429" }, { "nct_id": "NCT01860937", "title": "T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Relapsed B-Cell Acute Lymphoblastic Leukemia" ], "interventions": [ { "name": "leukapheresis or collection of PBMCs", "type": "PROCEDURE" }, { "name": "cyclophosphamide based chemotherapy regimens", "type": "DRUG" }, { "name": "modified T cells", "type": "BIOLOGICAL" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "26 Years", "sex": "ALL", "summary": "Up to 26 Years" }, "enrollment_count": 23, "start_date": "2013-05", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 2, "location_summary": "Boston, Massachusetts • New York, New York", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01860937" }, { "nct_id": "NCT04466072", "title": "Gut Microbiome and Ventricular Arrhythmias", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ventricular Tachycardia", "Ventricular Fibrillation", "Gut Microbiome" ], "interventions": [ { "name": "Stool test for microbial analysis", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "North Florida Foundation for Research and Education", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2020-11-30", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2022-04-18", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04466072" }, { "nct_id": "NCT04750954", "title": "Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuroendocrine Neoplasm" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Lutetium Lu 177 Dotatate", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Peposertib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 29, "start_date": "2021-07-22", "completion_date": "2026-12-30", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 5, "location_summary": "Duarte, California • Miami, Florida • Lexington, Kentucky + 2 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04750954" }, { "nct_id": "NCT03862222", "title": "Atlas of Retinal Imaging in Alzheimer's Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alzheimer Disease", "Mild Cognitive Impairment", "Mild Dementia", "Aging", "Cognitive Change" ], "interventions": [ { "name": "Retinal Imaging", "type": "OTHER" }, { "name": "Pupillometry", "type": "OTHER" }, { "name": "Contrast Sensitivity", "type": "OTHER" }, { "name": "Neuropsychological Evaluation", "type": "DIAGNOSTIC_TEST" }, { "name": "APOE genotyping", "type": "GENETIC" }, { "name": "blood draw", "type": "OTHER" }, { "name": "Gait Assessment", "type": "OTHER" }, { "name": "Actigraphy", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST", "GENETIC" ], "sponsor": "University of Rhode Island", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "55 Years to 80 Years" }, "enrollment_count": 165, "start_date": "2019-12-16", "completion_date": "2025-05-31", "has_results": false, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-10-21T12:31:06.135Z", "location_count": 4, "location_summary": "Clearwater, Florida • St. Petersburg, Florida • Kingston, Rhode Island + 1 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Kingston", "state": "Rhode Island" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT03862222" } ] }